RecruitingNCT01776905

In Vivo Real-time Detection of Circulating Melanoma Cells

Sponsor

University of Arkansas

Enrollment

75 participants

Start Date

Feb 1, 2013

Study Type

OBSERVATIONAL

Conditions

Melanoma

Summary

The objective of this clinical trial is to determine whether a Photoacoustic flow cytometry (PAFC)-based prototype device can detect circulating tumor cells (CTCs) in the blood of melanoma patients in vivo, in real time, and do so at detection limits at least one order of magnitude below the detection limits of currently existing ex vivo methods.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study tests a new laser-based device that can detect melanoma (skin cancer) cells circulating in the blood in real time — without needing to draw blood — to help doctors monitor how the cancer is spreading. **You may be eligible if...** - You are between 18 and 80 years old - You have been diagnosed with melanoma (confirmed by a tissue test) - You are able to sit still for about 90 minutes **You may NOT be eligible if...** - You have an active infection - You have a serious current medical or surgical condition - You have a brain disorder - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

University of Arkansas for Medical Sciences

Little Rock, Arkansas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01776905

Related Trials

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

NCT048999082 locations

Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

NCT028307241 location

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

NCT0711504313 locations

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma

NCT000403522 locations

Evaluation for NCI Surgery Branch Clinical Research Protocols

NCT000018231 location